| 2D Structure | |
| CID | 5281542 |
| IUPAC Name | [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate |
| InChI | InChI=1S/C24H30O11/c1-23(35-16(27)8-7-13-5-3-2-4-6-13)11-15(26)24(31)9-10-32-22(20(23)24)34-21-19(30)18(29)17(28)14(12-25)33-21/h2-10,14-15,17-22,25-26,28-31H,11-12H2,1H3/b8-7+/t14-,15-,17-,18+,19-,20-,21+,22+,23+,24-/m1/s1 |
| InChI Key | KVRQGMOSZKPBNS-FMHLWDFHSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C24H30O11 |
| Molecular Weight | 494.5 |
| synonyms | ['Harpagoside', '19210-12-9', 'E-harpagoside', '8KGS1DC5ZU', '[(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate', 'DTXSID101032528', '((1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-1,5,6,7a-tetrahydrocyclopenta(c)pyran-7-yl) (E)-3-phenylprop-2-enoate', 'DTXCID501517542', 'WS1531', 'WS 1531', '242-881-6', 'MFCD00017415', 'CHEBI:5625', '(1S,4aS,5R,7S,7aS)-4a,5-Dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate', 'SMR001233395', 'UNII-8KGS1DC5ZU', 'C24H30O11', 'Harpaside', '(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; Harpagoside; [1S-[1a,4aa,5a,7a(E),7aa]]-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-[(1-oxo-3-phenyl-2-propenyl)oxy]cyclopenta[c]pyran-1-yl-ss-D-glucopyranoside; E-Harpagoside', 'EINECS 242-881-6', 'Harpagoside (Standard)', 'Prestwick3_000988', 'BSPBio_001055', 'HARPAGOSIDE [WHO-DD]', 'MLS002154086', 'MLS002473324', 'SCHEMBL893387', 'BPBio1_001161', 'CHEMBL516702', 'MEGxp0_000469', 'orb1300175', 'Harpagoside, analytical standard', 'ACon0_000056', 'ACon1_000134', 'HY-N0396R', 'HMS2098E17', 'HMS2231N12', 'HY-N0396', 's9171', 'AKOS015896715', 'CCG-269650', 'LMPR0102070010', 'MH08976', 'NCGC00179325-01', 'NCGC00179325-02', 'NCGC00179325-04', 'AC-34268', 'AS-56071', 'AB00513986', 'CS-0008931', 'NS00101087', 'C09783', 'H10494', 'EN300-7357122', 'BRD-K07996107-001-01-7', 'BRD-K07996107-001-03-3', 'Harpagoside, primary pharmaceutical reference standard', 'Q25099323', 'Harpagoside, European Pharmacopoeia (EP) Reference Standard', '(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1H,4aH,5H,6H,7H,7aH-cyclopenta[c]pyran-7-yl (2E)-3-phenylprop-2-enoate', '(1S-(1alpha,4aalpha,5alpha,7alpha(E),7aalpha))-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-((allyl-1-oxo-3-phenyl)oxy)cyclopenta(c)pyran-1-yl-beta-D-glucopyranoside', '.BETA.-D-GLUCOPYRANOSIDE, (1S,4AS,5R,7S,7AS)-1,4A,5,6,7,7A-HEXAHYDRO-4A,5-DIHYDROXY-7-METHYL-7-(((2E)-1-OXO-3-PHENYL-2-PROPENYL)OXY)CYCLOPENTA(C)PYRAN-1-YL', '[(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate'] |
From Pubchem